Inventor · disambiguated record
David Matthew Shaw
Also filed as: SHAW DAVID · SHAW DAVID MATTHEW
23 granted patents·9 pending applications·184 citations·filing 2012–2025
95Inventor score
Top patents by PatentIndex Score
32 records- 0197US9718827B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2016·Granted Aug 1, 2017·22 cites·6 claims
- 0297US9340546B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted May 17, 2016·57 cites·6 claims
- 0396US8957078B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted Feb 17, 2015·19 cites·82 claims
- 0495US11834441B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Dec 5, 2023·4 cites·62 claims
- 0595US11827627B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Nov 28, 2023·3 cites·37 claims
- 0695US10647661B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted May 12, 2020·15 cites·106 claims
- 0794US11919887B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Mar 5, 2024·2 cites·21 claims
- 0894US9650381B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted May 16, 2017·19 cites·82 claims
- 0993US12247021B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 11, 2025·1 cites·24 claims
- 1093US11603351B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Mar 14, 2023·3 cites·27 claims
- 1193US10787452B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Sep 29, 2020·5 cites·20 claims
- 1292US8846917B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2012·Granted Sep 30, 2014·20 cites·9 claims
- 1391US12281057B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Apr 22, 2025·1 cites·15 claims
- 1490US2025223292A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1589US11117900B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2019·Granted Sep 14, 2021·2 cites·17 claims
- 1689US10815239B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Oct 27, 2020·3 cites·25 claims
- 1788US10392391B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Aug 27, 2019·4 cites·20 claims
- 1887US11370798B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·13 claims
- 1985US2025197381A1Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2082US12187731B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·19 claims
- 2180US12258333B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·22 claims
- 2279US10160760B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted Dec 25, 2018·3 cites·63 claims
- 2369US2025353836A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 2468US11485739B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Nov 1, 2022·0 cites·18 claims
- 2560US2024294512A1Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2658US2024400544A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2758US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2857US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2951US12440481B2Esters and carbamates as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
- 3051US2015291601A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3150US12441703B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
- 3250US2023257371A1Cyclic cyanoenone derivatives as modulators of keap1ALTMAN MICHAEL·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Matthew Shaw files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →